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Abstract
Background
Intermittent auscultation (IA) is the technique of listening to and counting the fetal heart rate
(FHR) for short periods during active labour and continuous cardiotocography (CTC) implies
FHR monitoring for longer periods. Although the evidence suggests that IA is the best way
to monitor healthy women at low risk of complications, there is no scientific evidence for the
ideal device, timing, frequency and duration for IA. We aimed to give an overview of the
field, identify and describe methods and practices for performing IA, map the evidence and
accuracy for different methods of IA, and identify research gaps.
Methods
We conducted a systematic scoping review following the Joanna Briggs methodology. Med-
line, EMBASE, Cinahl, Maternity & Infant Care, Cochrane Library, SveMed+, Web of Sci-
ence, Scopus, Lilacs and African Journals Online were searched for publications up to
January 2019. We did hand searches in relevant articles and databases. Studies from all
countries, international guidelines and national guidelines from Denmark, United Kingdom,
United States, New Zealand, Australia, The Netherlands, Sweden, Denmark, and Norway
were included. We did quality assessment of the guidelines according to the AGREEMENT
tool. We performed a meta-analysis assessing the effects of IA with a Doppler device vs.
Pinard device using methods described in The Cochrane Handbook, and we performed an
overall assessment of the summary of evidence using the GRADE approach.
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Results
The searches generated 6408 hits of which 26 studies and 11 guidelines were included in
the review. The studies described slightly different techniques for performing IA, and some
did not provide detailed descriptions. Few of the studies provided details of normal and
abnormal IA findings. All 11 guidelines recommended IA for low risk women, although they
had slightly different recommendations on the frequency, timing, and duration for IA, and the
FHR characteristics that should be observed. Four of the included studies, comprising 8436
women and their babies, were randomised controlled trials that evaluated the effect of IA
with a Doppler device vs. a Pinard device. Abnormal FHRs were detected more often using
the Doppler device than in those using the Pinard device (risk ratio 1.77; 95% confidence
interval 1.29–2.43). There were no significant differences in any of the other maternal or
neonatal outcomes. Four studies assessed the accuracy of IA findings. Normal FHR was
easiest to identify correctly, whereas identifying periodic FHR patterns such as decelera-
tions and saltatory patterns were more difficult.
Conclusion
Although IA is the recommended method, no trials have been published that evaluate proto-
cols on how to perform it. Nor has any study assessed interrater agreements regarding inter-
pretations of IA findings, and few have assessed to what degree clinicians can describe
FHR patterns detected by IA. We found no evidence to recommend Doppler device instead
of the Pinard for IA, or vice versa.
Introduction
The aim of fetal heart monitoring during labour is to monitor the health of the fetus, identify
those at risk of neonatal and long-term injury, reassure labouring women and staff that all is
well, and intervene in a timely manner when deviations from normal are observed. Although a
range of techniques are available for fetal monitoring during labour, including maternal per-
ception of fetal movements, the current standard is to assess the fetal heart rate (FHR) in con-
junction with uterine contractions. There are two main modalities for FHR monitoring–
Intermittent auscultation (IA) and continuous electronic monitoring using cardiotocography
(CTG). Organizations and stakeholders like the World Health Organization, International
Confederation of Midwives, and the International Federation of Gynecology and Obstetrics
(FIGO) recommend that IA should be used to monitor uncomplicated (low-risk) pregnancies
during labour and birth and for pregnancies in settings where no alternatives are available [1–
3]. A large RCT performed during the 1980s comparing IA and CTG showed that CTG was
associated with a lower risk of neonatal seizures in babies born following prolonged labour
and/or labour augmented with oxytocin (medication to speed up the labour process) [4].
Although CTG monitoring was not associated with long-term damage, such as cerebral palsy,
it was associated with increased risk of the need for a caesarean section and operative vaginal
delivery. Furthermore, it restricted the mobility of women in labour [4, 5].
IA is the technique of listening to and counting the fetal heartbeats for short periods of time
during active labour. It is usually performed using a Pinard stethoscope or a hand-held Dopp-
ler device, with the uterine contractions palpated by hand. The Pinard device is a hollow tube
Intermittent auscultation for fetal monitoring
PLOS ONE | https://doi.org/10.1371/journal.pone.0219573 July 10, 2019 2 / 21
often composed of wood or metal. The size of the Pinard varies from one country to another,
ranging from 15 to 60 cm. It amplifies sounds associated with the closing of the fetal heart
valves during each fetal cardiac cycle. With this device, the midwife can thus hear fetal heart
sounds, including any abnormal heartbeat rhythms, in real time, rather than from a secondary
source [6]. The advantages of the Pinard device are it is low cost, available in all settings and
no consumables are needed.
The Doppler device is a small hand-held ultrasound transducer that uses the “Doppler
effect” to provide an audible simulation of the fetal heartbeats. Its advantages are that it can be
used in various maternal positions, including water immersion, and that the real-time audio
sound is shared with everyone present in the room. It is more expensive than the Pinard, and
consumables like batteries and spare parts are needed.
In contrast, although the evidence suggests that IA is the best way to monitor healthy
women with healthy pregnancies at low risk of complications, many maternity care providers
prefer continuous CTG for all women [7].
Unfortunately, because CTG is used far more often than recommended in high-, medium-,
and low-risk settings worldwide, skills needed to perform IA–especially when using the Pinard
device–are rapidly disappearing from midwifery practice [8, 9], reducing the opportunity for
women to benefit from the use of this technique. To our knowledge, there is no scientific evi-
dence for the ideal device, timing, frequency and duration for IA.
This systematic scoping review aimed to give an overview of the field, identify and describe
methods and practices for performing IA, map the evidence (or lack thereof) for various meth-
ods, and identify research gaps. Specific aims were to 1) systematically map the techniques and
protocols for performing IA; 2) map any effect or evidence of the accuracy of IA; and 3) map
the findings to support recommendations given in international and national guidelines.
Methods
A study protocol was developed and published before initiating the literature search [10]. We
then conducted a scoping review following the methods described by the Joanna Briggs Insti-
tute [11]. In March 2017, we completed a systematic literature search in MEDLINE, EMBASE,
Cinahl, Maternity & Infant Care, Cochrane Library, SveMed+, Web of Science, Scopus, Lilacs,
and African Journals Online (AJOL). The first step was an initial search of two databases rele-
vant to the topic (MEDLINE and Cinahl) to identify relevant search terms related to labour
and IA. Then, a highly sensitive search strategy (step two) was developed using relevant subject
headings (e.g., MeSH) and free-text words (.tw) for each of the study components and adapted
it to all included databases. In January 2019, we updated the entire search. The search is
described in detail in the S1 Table.
Each search was designed broadly, regardless of the study design and language. We
included scientific studies that described or assessed all forms of IA during labour, and in lan-
guages understood by members of the study group (Danish, Dutch, English, French, German,
Icelandic, Norwegian, Swedish and Turkish).
We also included FHR monitoring guidelines in the review. We limited the search for
guidelines to international guidelines and national guidelines from the United Kingdom, Aus-
tralia, New Zealand, United States, Canada, Denmark, Norway, Sweden and The Netherlands.
Exclusion criteria were: studies or guidelines published in other languages than those men-
tioned above, articles not assessed as scientific studies, not containing information according
to the aims of the scoping review, commentaries, expert opinions, letters to the editor, review
or if we were unable to retrieve the article in full text.
Intermittent auscultation for fetal monitoring
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A senior librarian (EK) performed the literature searches. Two reviewers then indepen-
dently screened all titles and abstracts to determine eligibility based on the inclusion criteria
and labelled the articles as “included,” “excluded,” or “uncertain” (AK, EB). All articles labelled
“included” or “uncertain” by at least one of the reviewers underwent full-text assessment by
pairs of reviewers (AK, EH, ASDP, SK, EB). Disagreements were discussed by a group of
reviewers until consensus was reached.
A data charting form was developed and completed for each study. For scientific articles,
relevant data included a description of the population, sample size, concept (phenomena of
interest or study aim), context (details about the study setting), device used for IA, details on
how IA was performed, any effects of the methods of performing IA, and results from studies
reporting IA accuracy. Regarding IA, accuracy is how well observers can describe IA charac-
teristics compared to a pre-defined reference standard. Recommendations for IA were
extracted from the included guidelines.
According to the Joanna Briggs methodology [11], we did not perform quality assessments
of the studies that described devices or modes for performing IA. We did perform quality
assessments of the included guidelines by assessing if: 1) all relevant areas and/or professions
were included; 2) views and preferences of target populations were sought; 3) the targeted
users were defined; 4) systematic methods were used to search for evidence; 5) criteria for
selecting evidence were clearly described; 6) strengths and limitations of the body of evidence
were clearly described; 7) methods for formulating recommendations were clearly described;
8) the guidelines were externally reviewed by experts before publication [12].
We did descriptive summaries of studies and guidelines. The trials comparing IA with the
Doppler device vs. Pinard device were combined in a meta-analysis performed according to
the methods described in the Cochrane Handbook [13]. Studies that met the inclusion criteria
were critically appraised using the “risk of bias”’ tool, and outcomes were analysed by calculat-
ing the pooled risk ratio with 95% confidence intervals and a random-effects model. We also
conducted sensitivity analyses [13] and an overall assessment of the summary of evidence
using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE)
approach [14].
Results
The electronic search generated 6401 hits, with another 7 studies found by hand search. After
deleting duplicates, 4081 records were screened by reading their titles and abstracts. At this
stage, 3804 records were excluded, mainly because they were unrelated to the topic of interest.
Altogether, 276 papers then underwent full-text review, resulting in 239 papers being excluded.
Finally, 37 papers (26 articles [4, 9, 15–38] and 11 guidelines [1–3, 39–46]) were included in
the review. Characteristics of the included papers are shown in Table 1 and Table 2.
Fig 1 gives an overview of the inclusion process, and the S2 Table lists the papers excluded
after full-text assessment and the reason for exclusion.
Findings from the studies
Five of the 26 studies were from African countries [15, 16, 18, 26, 37], two from India [19, 21],
one from the Middle East [20], seven from Europe [4, 22, 23, 27, 29, 34, 38], seven from North
America [24, 28, 30–33, 36] and four were from Australia/New Zealand [9, 17, 25, 35]. The
date range was from 1968 to 2019 (Table 1). Among the 26 articles, 25 were original studies
(Table 1). Altogether 17 studies (in 18 articles) [4, 9, 17, 19–23, 25, 27–29, 31–34, 37, 38] pro-
vided descriptions of devices and techniques for performing IA, one of which also presented
and evaluated a decision-making framework for fetal heart monitoring in low-risk women [9]
Intermittent auscultation for fetal monitoring
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Table 1. Characteristics of included studies.
Author, year, country Aim of study Design and study population Information of interest
Studies describing devices and modes of performing intermittent auscultation (IA)
Smith et al, 2019,
Ireland [38]
Compare the effect on caesarean section rates
of admission CTG vs. IA
RCT
3034 low-risk women in labour (1513 IA,
1521 admission CTG)
Descriptions of IA practices (device,
frequency, timing, duration)
Kamala et al, 2018,
Tanzania [37]
Compare continuous fetal heart rate
monitoring using the Moyo strap-on
monitor with IA using a Pinard for the
detection of FHR abnormalities
Pre- and post-intervention study.
1640 low-risk women monitored with a
Pinard and 2442 with a Moyo device
Descriptions of IA practice (device, frequency,
timing, abnormal FHR)
Maude et al, 2014, NZ
[9]
Describe the implementation of the
Intelligent Structured Intermittent
Auscultation (ISIA) framework in one
maternity unit
Mixed method pre- and post-intervention
study.
Audit of 511 medical records before
intervention and 422 after intervention
Descriptions of IA practices (device,
frequency, timing, duration, definitions of
normal and abnormal FHR, assessments of
uterine contractions, fetal movements and
maternal pulse).
Presentation and evaluation of a decision-
making framework for fetal heart monitoring
in low-risk women
Rathore et al, 2011,
India [19]
Evaluate fetal scalp stimulation test as an
adjunct to IA in diagnosis of intrapartum
fetal acidosis
Prospective observational cohort
750 women in labour, with fetal heart
abnormalities and/or thick meconium
stained amniotic fluid
Descriptions of IA practices (device,
frequency, timing, duration)
Maude et al, 2009, NZ
[17]
Explore the fetal heart rate monitoring
practices of midwives and doctors and
determine compliance with a NZ evidence-
based guideline for fetal heart monitoring
Retrospective audit of
193 randomly selected medical records
undertaken over six months in 2006
Descriptions of IA practices (device,
frequency, timing, duration, definitions of
normal and abnormal FHR, assessments of
uterine contractions, fetal movements and
maternal pulse, documentation practices for
IA).
Soltani, 2009, Iran [20] Present and evaluate a new electronic device
for IA
Presentation of a new device for IA, with
evaluations from 28 medical trainees
Description of a device for IA, a Personal
Digital Assistant, an electronic stethoscope
attached to a hand-held computer.
Madaan & Trivedi,
2006, India [21]
Compare the effect of EFM and IA for
intrapartum fetal monitoring
RCT
100 women included (50 EFM, 50 IA), with
post caesarean pregnancies and no
contraindications for a vaginal delivery
Descriptions of IA practices (frequency,
timing, duration, definition of abnormal
FHR)
Impey et al, 2003,
Ireland [22]
Compare the effect on neonatal outcome of
admission CTG vs. IA
RCT
8580 low-risk women included (4320
admission CTG, 4308 IA)
Descriptions of IA practices (frequency,
timing, duration)
Mires et al, 2001, UK
[23]
Compare the effect on neonatal outcome of
admission CTG vs. IA and levels of obstetric
interventions in a low-risk obstetric
population
RCT
3751 low-risk women included (1866
admission CTG, 1885 IA)
Descriptions of IA practices (device, duration)
Gilles et al, 1997,
Australia [25]
Survey the use of IA throughout maternity
units in Western Australia, compare
protocols and suggest a protocol for use in
women with low-risk labours
Survey to all hospitals in Western Australia Descriptions of IA practices (frequency,
definition abnormal FHR). A new protocol
for IA based on review of practices and
research literature
Vintzileos et al, 1993,
Greece [27]
Compare the effect on neonatal outcome of
EFM vs. IA
RCT
1428 women with singleton living fetus and
gestational age�26 weeks included (746
EFM, 682 IA).
Description of IA practices (device, frequency,
timing, duration, definition of abnormal FHR,
assessments of uterine contractions)
Luthy et al, 1987,
Canada and USA [28]
Compare the effect on neonatal outcome of
EFM vs. IA
RCT
246 women with preterm singleton
pregnancies with fetal weights 700–1750 g
included (122 EFM. 124 IA)
Description of IA practices (device, frequency,
timing, duration,definition of normal FHR,
definition of abnormal FHR, assessments of
uterine contractions)
Neldam et al, 1986,
Denmark [29]
Compare the effect on maternal and neonatal
outcome of EFM vs. IA
RCT
969 low- and high-risk women included (482
EFM, 487 IA)
Description of IA practices (device, frequency,
timing, duration, definition of normal
baseline, definition of abnormal FHR)
(Continued)
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Table 1. (Continued)
Author, year, country Aim of study Design and study population Information of interest
MacDonald et al, 1985,
Ireland [4]
Compare the effect on maternal and neonatal
outcome of EFM vs. IA
RCT
12964 women with a live fetus and
gestational age� 28 weeks were included
(6474 EFM, 6490 IA)
Description of IA practices (devise, frequency,
duration, definition of abnormal FHR)
Appelgate et al, 1979,
USA [31] and
Haverkamp et al, 1976,
USA [33]
Compare the effect on maternal and neonatal
outcome of EFM vs. IA
RCT
483 high-risk women included (242 EFM,
241 IA)
Description of IA practices (frequency,
timing, duration, definition of normal
baseline, definition of abnormal FHR)
Haverkamp et al, 1979,
USA [32]
Compare the effect on maternal and neonatal
outcome of EFM alone or EFM with option
to FBS or IA
RCT
669 high-risk women included (220 EFM
alone, 223 EFM with option to FBS, 226 IA)
Description of IA practices (frequency,
timing, duration, definition abnormal FHR)
Kelso et al, 1978, UK
[34]
Compare the effect on maternal and neonatal
outcome of EFM vs. IA
RCT
504 low-risk women included (253 EFM, 251
IA)
Description of IA practices (device, frequency,
timing, duration, definition normal baseline)
Studies describing devices and modes of performing, and assessing the effect of different modes of IA
Kamala et al, 2018,
Tanzania [15]
Compare the effect on maternal and neonatal
outcome of IA with Doppler device vs. IA
with Pinard
RCT
2844 women with cephalic presentation,
gestational age� 37 weeks and normal FHR
at admission included (1421 Doppler, 1423
Pinard)
Description of IA practices (device, frequency,
timing, definition of abnormal baseline).
Effects of Doppler device vs. Pinard (detection
of abnormal FHR, caesarean section, Apgar
score < 7 at 5 min, bag mask ventilation
attempted, admission to neonatal unit, fresh
stillbirth, perinatal death, composite outcome)
Mdoe et al, 2018,
Tanzania [16]
Compare the effect on maternal and neonatal
outcome of IA with Doppler device vs. IA
with Pinard
RCT
2684 women with cephalic presentation,
gestational age� 36 weeks and normal FHR
at admission included (1309 Doppler device,
1375 Pinard)
Description of IA practices (device, definition
of normal and abnormal baseline.
Effects of Doppler device vs. Pinard (detection
of abnormal FHR, time interval abnormal
FHR to birth, caesarean section, bag mask
ventilation, Apgar score <7 at 1 and 5 min,
fresh stillbirth, early neonatal death, admitted
to neonatal area, adverse perinatal outcome)
Byaruhanga et al, 2015,
Uganda [18]
Compare the effect on maternal and neonatal
outcome of IA with Doppler device vs. IA
with Pinard
RCT
1971 women with a singleton pregnancy, in a
cephalic position with gestational age > 37
weeks (992 Doppler device, 979 Pinard)
Description of IA practices (device, frequency,
timing, duration, how FHR was counted,
definition of normal baseline, definition of
abnormal FHR, assessment of maternal pulse)
Effects of Doppler device vs. Pinard (detection
of abnormal FHR, Apgar score < 7 at 5 min,
admission to special care unit, neonatal
encephalopathy, caesarean section)
Mahomed et al, 1994,
Zimbabwe [26]
Compare the effect on maternal and neonatal
outcome of IA with Doppler device by a
research midwife, Pinard by a research
midwife, Pinard by midwife on duty or
intermittent CTG
RCT
1255 high- and low-risk women with a
singleton pregnancy, in a cephalic position,
gestational age >37 weeks, singleton,
cephalic present, with normal FHR at
admission were included (312 Doppler device
by research midwife, 310 Pinard by research
midwife, 315 Pinard by midwife on duty, 318
intermittent CTG)
Description of IA practices (device, frequency,
timing)
Effects of Doppler device vs. Pinard (duration
of labour, caesarean section, assisted vaginal
delivery, spontaneous vaginal delivery, Apgar
score <6 at 5 min, fits in neonatal unit,
hypoxic encephalopathy, stillbirth or neonatal
death)
Studies assessing the accuracy of IA
Simpson et al, 1999,
Canada [24]
Investigate if the accuracy of auscultation
could be improved with the use of a heart
rate meter
Accuracy study
15 experienced nurses and 15 obstetric
residents were asked to assess six FHR
recordings/traces by counting alone,
counting with the help of a meter and visual
assessment
Description of the accuracy of baseline
variability, periodic changes and if the FHR
pattern was assessed as reassuring or non-
reassuring when counting alone and counting
by the help of a meter
(Continued)
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(S1 Fig). Four were randomized trials comparing the effects of IA using Doppler vs. Pinard
devices and provided descriptions of the devices and modes [15, 16, 18, 26]. Four studies
assessed the accuracy of IA [24, 30, 35, 36] (Table 1).
Devices used for IA. The Pinard fetoscope, DeLee fetoscope, and Doppler device (battery
or wind-up) were the common tools used to perform IA. Some studies did not specify the
device [21, 22, 25, 31–33, 35], and two studies just called it “a stethoscope” [19, 29]. There were
no detailed descriptions of Pinard or DeLee fetoscopes in the studies in which they were used
[4, 9, 15–18, 26, 28, 34, 38]. Seven studies provided information of the type of the Doppler or
electronic device [15, 16, 18, 26, 27, 34, 37] (S3 Table). One study [20] described a new inter-
vention, an electronic stethoscope (the stethoscope was attached to a hand-held computer).
The authors showed examples–one with a stethoscope attached to a cell phone and the other a
Pinard device attached to an MP3 player. According to the authors, in addition to real-time
fetal heart sound analyses, the device could create and save images of the sounds.
Frequency, timing, and duration of auscultation. The studies described slightly different
techniques for performing IA. Some did not provide detailed descriptions. The S3 Table pro-
vides a detailed overview of each study.
During the first stage of labour, the frequency of auscultation was described as either every
15 min [4, 19, 21, 27, 28, 31–34, 38], 15–30 min [9, 17] or 30 min [15, 16, 18, 37]. One study
reported the frequency as every 30 min in low-risk women and every 15–30 min in women at
higher risk [25]. Another study reported IA frequency at every 30 min until 5-cm cervical dila-
tation and then every 15 min [29]. Timing of auscultation was described as either after a con-
traction [4, 18, 19, 22, 31–33, 37, 38], during and after a contraction [21, 23, 26, 34], between
and after contractions [28], and between, during, and after contractions [9, 17, 27]. One study
reported auscultation during fetal movement as part of a baseline assessment [17]. Duration of
each FHR counting varied from 15 to 60 s (S3 Table).
During the second stage of labour, the most common frequencies of auscultation were
every 5 min or after each contraction [9, 17, 19, 21, 22, 27, 28, 31–33, 38]. The most common
frequencies of auscultation were every 5 min or after each contraction [9, 17–19, 21, 22, 25, 27,
28, 31–33]. One study reported a frequency of every 15 min [15], and two every 5–15 min [16,
37]. One study reported the frequency as every 15 min in low-risk women and after most con-
tractions in those at higher risk [25]. Most studies had similar recommendations for the timing
of auscultation for the first and second stages (S3 Table).
Table 1. (Continued)
Author, year, country Aim of study Design and study population Information of interest
Strong & Jarles, 1992,
USA [36]
Evaluate current practice of auscultation on
the detection of decelerations
Accuracy study
120 nurses and physicians were asked to
assess an intrapartum FHR recording
containing a deceleration
Description of accuracy of baseline,
deceleration nadir and deceleration duration
Miller et al, 1984, USA
[30]
Define what characteristics of FHR and FHR
patterns can be recognised by IA
Accuracy study
16 nurses and 16 physicians were asked to
assess eight intrapartum FHR recordings
containing a contraction
Descriptions of accuracy of baseline,
accelerations without periodic change and
non-uniform), saltatory pattern, decelerations
(early, variable, late with good variability and
late with diminished variability
Day et al, 1968,
Australia [35]
Determine accuracy and usefulness of clinical
measurement of the FHR
Accuracy study
A trained midwife, a resident obstetrician
and two medical students did clinical
auscultations (126 observations in 90
women)
Descriptions of auscultation errors (random
error, error biased towards normality, error
based on inability to count during
contractions)
https://doi.org/10.1371/journal.pone.0219573.t001
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Table 2. Characteristics and quality of included guidelines.
Organisation/country, year, guideline title,
developed by
Description Quality assessment
World Health Organization, 2018 [1]
Intrapartum care for a positive childbirth
experience
World Health Organization
Guideline including 56 recommendations for intrapartum
care. Recommendations 13 and 18 are about IA
• The guideline group included persons from all relevant
areas/professions
• Views and preferences of target population were sought
• The target users of the guideline are clearly defined
• Systematic methods were used to search for evidence
• Criteria for selecting evidence are clearly described
• Strengths and limitations of the body of evidence are
clearly described
• Methods for formulating recommendations are clearly
described
• The guideline were externally reviewed by experts before
publication
Overall quality assessment: good
International Confederation of Midwives
(ICM), 2017 [2]
Use of Intermittent Auscultation for
Assessment of Foetal Wellbeing during Labour
ICM
Position statement on use of IA • Unclear who developed the statement
• Views and preferences of target population have not
been sought
• The target users of the guideline are not defined
• Unclear if systematic methods were used to search for
evidence
• Criteria for selecting evidence are unclear
• Strengths and limitations of the body of evidence are not
described
• Methods for formulating recommendations are unclear
• Unclear if the guideline were externally reviewed by
experts before publication
Overall quality assessment: unclear (Position statement,
quality assessment meant for guidelines aimed to be
evidence-based)
International Federation of Gynecology and
Obstetrics (FIGO), 2015 [3]
FIGO consensus guidelines on intrapartum
fetal monitoring
D. Lewis and S. Downe for the FIGO
Intrapartum Fetal Monitoring Expert
Consensus Panel
Consensus guideline describing devices for IA, discusses
advantages and disadvantages of the devices, providing
recommendations for when to continue IA in settings
where CTG is available and techniques for how to perform
IA
• The guideline development group included 2 midwives,
the FIGO Intrapartum Fetal Monitoring Expert Panel of
45 obstetricians
• Views and preferences of target population are partly
described
• The target users of the guideline are defined
• Unclear if systematic methods were used to search for
evidence
• Criteria for selecting evidence are unclear
• Strengths and limitations of the body of evidence are not
described
• Methods for formulating recommendations are unclear
• The guideline were not externally reviewed by experts
before publication
Overall quality assessment: unclear (Consensus guideline,
quality assessment meant for guidelines aimed to be
evidence-based)
Denmark, 2017 [41]
Intrapartum fetal surveillance–indications
The Danish Society of Obstetricians and
Gynaecology (DSOG)
Guideline providing recommendations on when to use IA,
intermittent CTG and continuous CTG during
intrapartum care
• The guideline development group included 2 midwives
and 15 obstetricians
• Views and preferences of target population were not
sought
• The target users of the guideline are not clearly defined
• Systematic methods were used to search for evidence
• Criteria for selecting evidence are partly described
• Strengths and limitations of the body of evidence are not
always clearly described
• Methods for formulating the recommendations are
clearly described
• Unclear if the guideline were externally reviewed by
experts before publication
Overall quality assessment: moderate
(Continued)
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Table 2. (Continued)
Organisation/country, year, guideline title,
developed by
Description Quality assessment
Norway, 2014 [40]
Intrapartum fetal surveillance, cord clamping
and cord-blood sampling for blood gas
analyses
Norwegian Society of Gynecology and
Obstetrics (NGF)
Guideline with recommendations for intrapartum fetal
monitoring, cord clamping and cord-blood gas analyses
• The guideline development group included 1 midwife
and 8 obstetricians
• Views and preferences of target population were not
sought
• The target users of the guideline are clearly defined
• Unclear to what degree systematic methods were used to
search for evidence
• Strengths and limitations of the body of evidence are not
clearly described
• Methods for formulating the recommendations are
unclear
• The guideline was not externally reviewed by experts
before publication
Overall quality assessment: unclear
Sweden, 2015 [42]
Fetal surveillance in active labour.
Recommendations for clinical practice
The insurance company for Swedish regions
(LØF)
Guideline for fetal monitoring during active labour • The guideline development group included 1 midwife, 1
neonatologist, 3 obstetricians
• Views and preferences of target population were not
sought
• The target users of the guideline are not defined
• Unclear if systematic methods were used to search for
evidence
• Strengths and limitations of the body of evidence are not
described
• Methods for formulating recommendations are not
described
• Unclear if the guideline was externally reviewed by
experts before publication
Overall quality assessment: unclear
England and Wales, 2014 [39]
Intrapartum care. Care of healthy women and
their babies during childbirth
National Institute of Clinical Excellence
(NICE)
Guideline providing recommendations for intrapartum
care. Recommendations Chapters 1.4., 1.10 and 1.13
include recommendations on IA
Chapters 1.4 and 1.10 were updated in 2017
• The working group included 3 midwives, 3
obstetricians, 1 neonatologist, 1 obstetric anesthesiologist,
2 patient/carer/consumer representatives
• Views and preferences of the target population were
sought
• The target users of the guideline are clearly defined
• Systematic methods were used to search for evidence
• Criteria for selecting evidence are clearly described
• Strengths and limitations of the body of evidence are
clearly described
• Methods for formulating recommendations are clearly
described
• The guidelines were externally reviewed by stakeholders
before publication
Overall quality assessment: good
Canada, 2007, reaffirmed 2018 [43]
Fetal health surveillance: Antepartum and
intrapartum consensus guideline
The Society of Obstetricians and
Gynaecologists of Canada (SOGC) and
British Columbia Perinatal Health Program.
Guideline for intrapartum fetal monitoring • Principal authors were 2 medical doctors and 1 nurse;
Consensus committee included 11 medical doctors, 1
midwife, 1 nurse, 1 unknown profession
• Unclear if views and preferences of the target population
were sought
• The target users of the guideline are clearly defined
• Unclear to what degree systematic methods were used to
search for evidence
• Criteria for selecting evidence are unclear
• Strengths and limitations of the body of evidence are
clearly described
• Methods for formulating recommendations are clearly
described
• The guidelines were externally reviewed before
publication
Overall quality assessment: moderate (Consensus
guideline, quality assessment meant for guidelines aimed
to be evidence-based)
(Continued)
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The most common duration of each auscultation was a full minute but varied from 15 to at
least 60 s. Two of the studies reported that auscultations were performed for periods of 10 min
[15, 26]. We understood this to mean several frequent auscultations rather than one reading
that lasted 10 min.
Observations during auscultation. The following observations were reported: baseline or
average FHR [4, 9, 15, 16, 18, 19, 25, 27–29, 31, 32, 34]; the presence or absence of FHR
decreases (decelerations) and increases (accelerations) [9, 17–19, 26–29, 31–33]; FHR rhythm
[9, 18]; maternal pulse [9, 17]; frequency and duration of contractions [9, 17]; uterine activity
and tone [9, 17, 27]; fetal movements [9, 17] (S3 Table).
Table 2. (Continued)
Organisation/country, year, guideline title,
developed by
Description Quality assessment
Australia and New Zealand, 2014 [44]
Intrapartum fetal surveillance. Clinical
guideline.
The Royal Australian and New Zealand
College of Obstetricians and Gynaecologists
(RANZCOG)
Guideline for intrapartum fetal monitoring • The guideline development group included 2 midwives,
8 obstetricians, 2 MFM specialist, 1 medical specialist, 3
RANZOG administrative staff. In addition, a NZ
consultation group with 3 obstetricians, 2 midwives.
• Views and preferences of the target population were not
sought
• The target users of the guideline are clearly defined
• Systematic methods were used to search for evidence
• Criteria for selecting evidence are clearly described
• Strengths and limitations of the body of evidence are
clearly described
• Methods for formulating recommendations are clearly
described
• The guideline was not externally reviewed by experts
before publication
Overall quality assessment: moderate
USA, 2015 [45]
ACNM Clinical Bulletin: Intermittent
auscultation for intrapartum fetal heart rate
surveillance
American College of Nurse-Midwives
(ACNM)
Guideline for IA during childbirth • The guideline development group included 6 midwives
• Views and preferences of the target population have
been sought
• The target users of the guideline are not defined
• Unclear if systematic methods were used to search for
evidence
• Criteria for selecting the evidence are unclear
• Strengths and limitations of the body of evidence are
clearly described
• Methods for formulating the recommendations are
clearly described
• Unclear if the guideline was externally reviewed before
publication
Overall quality assessment: moderate
USA, 2018 [46]
AWHONN position statement: Fetal heart
monitoring
Association of Women’s Health, Obstetric
and Neonatal Nurses (AWHONN)
Position statement for fetal heart monitoring during
childbirth
• The guideline development group is not described
• The views and preferences of the target population were
not sought
• The target users of the guideline are clearly defined
• Unclear if systematic methods were used to search for
evidence
• Criteria for selecting the evidence are unclear
• Strengths and limitations of the body of evidence are not
described
• The methods for formulating the recommendations are
unclear
• Unclear if the guidelines were externally reviewed before
publication
Overall quality assessment: unclear (Position statement,
quality assessment meant for guidelines aimed to be
evidence-based)
https://doi.org/10.1371/journal.pone.0219573.t002
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Definitions of normal and abnormal FHR. Few of the included studies provided detailed
descriptions or definitions of normal and abnormal IA findings. Normal FHR baseline was
described as 110–160 beats per minute (bpm) [9, 17, 18, 38] or 120–160 bpm [16, 27–29, 31–
34, 37]. One study described normal auscultation findings as follows: average FHR 110–160
Fig 1. PRISMA flow diagram of included studies.
https://doi.org/10.1371/journal.pone.0219573.g001
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bpm, FHR increases of�15 bpm (accelerations), absence of FHR decreases (decelerations),
regular rhythm–all in combination with normal uterine activity and tone [9].
Abnormal findings were most commonly described as “below or above the normal base-
line” but also as the presence of deceleration and the absence of acceleration. The S3 Table pro-
vides a more detailed description of definitions of normal and abnormal FHR.
Findings from the guidelines
The WHO international guidelines [1] and the England and Wales NICE guidelines [39] were
found to be of good quality, meaning that they established quality criteria. This included the
requirement that relevant professions were involved in the guideline development group, that
views and preferences of service users were sought and that systematic methods were used to
search for the evidence. The rest of the included guidelines were assessed as either of moderate
or unclear quality (Table 2). Three guidelines of unclear quality were either position statements
or consensus guidelines and did not claim to be evidence based [2, 3, 54]. In five of the seven
national guidelines, obstetricians or medical doctors comprised an absolute majority of the
guideline development groups [40–44]. One guideline was developed by midwives only [45].
Only three of the 11 guidelines stated clearly that users were represented in the guideline
development group or that their views and preferences were sought in other ways [1, 39, 45].
Three guidelines stated clearly that systematic methods were used to search for the evidence
[1, 39, 42].
The Swedish guideline recommended admission CTG for all women, and intermittent
CTG or IA for low-risk women [42]. We assessed the Swedish guidelines as being of unclear
quality (Table 3). The Canadian guideline was updated the most recently in 2007 [47], and was
reaffirmed in 2018, with no updates or changes [43]. None of the other guidelines had been
established before 2014 (Table 2).
The FIGO guideline recommended IA for fetal monitoring in all settings if CTG is not
available, and stated that IA may be used in settings where CTG is available [3]. The Swedish
guidelines recommended, for low-risk women, IA or intermittent CTG (20–30 min every sec-
ond hour with IA in between) during the first stage of labour and IA or continuous CTG dur-
ing the second stage of labour [42]. The remaining nine guidelines recommended IA, but not
CTG, in low-risk women. Whereas four of the guidelines explicitly stated that admission CTG
was not recommended in low-risk women [1, 39, 40, 43], the Swedish guideline recommended
admission CTG for all women [42]. The remaining six guidelines did not provide any recom-
mendation on fetal monitoring on admission. The S4 Table provides detailed information
about the recommendations from each guideline.
Recommended devices for IA. Three of the guidelines did not provide recommendations
on the device to be used for IA
[42, 44, 46]. The others recommended both the Doppler device and the Pinard or DeLee
fetoscope.
Recommended frequency, timing and duration of auscultation. During the first stage
of labour, most guidelines recommended a frequency of every 15–30 min [1, 40–46]. Two
guidelines recommended a frequency of 15-min intervals [3, 39], while one offered no recom-
mendations regarding the frequency of auscultation [2].
During the second stage of labour, one guideline recommended a frequency of every 5–15
min [46], two offered no recommendation [2, 39], and the remaining eight guidelines recom-
mended auscultation every 5 min or after each contraction.
One of the guidelines recommended that the frequency of auscultation should be individu-
alised to the contraction pattern, maternal activity, and interventions that may affect the FHR.
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The same guideline also recommended listening between contractions to assess the FHR base-
line [45].
Six guidelines recommended that auscultation should be performed during and after a con-
traction [1, 3, 40, 41, 44, 45], two immediately after a contraction [39, 42], and one between
contractions [43]. Two guidelines did not describe the timing of auscultation [2, 46]. Three of
the guidelines recommended auscultating over three contractions if the FHR was not always in
the normal range [1, 39, 41]. Among the guidelines recommending auscultation for at least 60
s, one recommended 15–60 s [43] and another 30–60 seconds [45]. Two others did not
describe the duration of auscultation [2, 46].
Some of the guidelines provided detailed descriptions on how to count and observe the
FHR, whereas others did not. Most guidelines recommended documentation of the FHR as a
single count (in bpm). Others simply stated that the FHR rhythm and presence or absence of
decelerations and accelerations should be documented. The S4 Table describes in detail the
recommendations in each guideline.
Recommended observations during auscultation. Some of the guidelines recommended
observation of the frequency or pattern of contractions [3, 41–43, 45], fetal movements [3, 39],
and maternal pulse to differentiate it from the FHR [3, 39, 42, 43].
Definitions of normal and abnormal FHR. Most guidelines did not provide detailed
descriptions of normal and abnormal auscultation findings, except for the FHR baseline. Den-
mark and Norway guidelines defined the normal baseline as 110–150 bpm [40, 41], whereas all
other guidelines defined it as 110–160 bpm. One guideline provided a systematic classification
of normal and abnormal auscultation findings [45]. Its normal findings included a baseline of
110–160 bpm, regular rhythm, and the absence of FHR decreases or decelerations from the
baseline. Abnormal findings included any of the following: irregular rhythm, presence of FHR
decreases or decelerations from the baseline, tachycardia (>160 bpm for>10 min), or brady-
cardia (<110 bpm for>10 min) [45].
Effects of various IA modes
Four studies were included in a meta-analysis comparing the effects of IA performed with a
Pinard vs. a Doppler device [15, 16, 18, 26]. The methods of the meta-analysis, risk-of-bias
assessments and sensitivity analyses are described in detail in S1 Text. The studies were from
Uganda, Tanzania and Zimbabwe and included 8436 women and their babies. An Apgar score
<7 after five minutes and caesarean sections were the primary endpoints. Secondary endpoints
were a composite neonatal outcome (fresh stillbirth, early neonatal death at<24 h, admission
to the neonatal intensive care unit) and the following single-outcome measures: stillbirth/neo-
natal death, assisted vaginal delivery, detection of an abnormal FHR.
Among the women randomized to IA by different devices, abnormal FHR was detected
more often using the Doppler device than with the Pinard device [risk ratio 1.77, 95% confi-
dence interval 1.29–2.43]. The difference, however, did not affect the clinical outcomes, as
there were no significant differences in any of the other outcomes (Table 3).
For the sensitivity analyses, one of the studies [26] was excluded, resulting in lower hetero-
geneity, but it did not affect the results significantly (S1 Text). The GRADE assessment of the
overall quality of evidence found low confidence in the effect estimates, except for stillbirth
and neonatal death, which were assessed as moderate (S1 Text).
Accuracy of IA
We identified four studies that assessed the accuracy of auscultation [24, 30, 35, 36]. Three of
the studies were performed in classroom settings, where the observers listened to recorded
Intermittent auscultation for fetal monitoring
PLOS ONE | https://doi.org/10.1371/journal.pone.0219573 July 10, 2019 13 / 21
soundtracks [24, 30, 36] and one in a clinical setting where the observers auscultated labouring
women [35]. CTG signals recorded simultaneously were regarded as the gold standard com-
parator. One study [24] found that counting alone was associated with underestimation of the
FHR. When a heart rate meter was displayed together with the soundtrack (i.e., the FH was
displayed on screen), the assessments were significantly more accurate, and the intra-observer
variation decreased.
Another study investigated the characteristics of FHR and FHR patterns that could be rec-
ognised by IA [30]. One-third of the observers failed to identify periodic FH patterns such as
decelerations and a saltatory pattern (wide, rapid oscillations of the FHR). Baseline was the
most likely to be scored correctly, and the saltatory pattern was the most difficult. The third
study [35] investigated the accuracy of clinical auscultation of FHR. The authors described
three types of auscultation errors: random error; error biased toward normality when the FHR
was fast or slow; error based on inability to count FHR during contractions. In the fourth
study [36], a recording of intrapartum FHR was played to 120 physicians and nurses. They
were asked to estimate the baseline and then the duration and nadir of a deceleration. Mean
estimates were not significantly different from the actual values, but individual assessments
varied widely.
Discussion
Summary of evidence
We identified different protocols for frequency, timing and duration of IA. Studies assessing
FHR auscultation against a “reference” or “gold standard” described deviations in interpreta-
tions. The Doppler device and the Pinard fetoscope were the most commonly reported devices
for undertaking IA. We carried out a meta-analysis assessing IA performed by a Doppler
device vs. Pinard device and found no difference in clinical outcomes. The quality of the
included guidelines varied.
We are aware that the transducer from the CTG machine is often used for IA. We were,
however, not able to identify any studies that described this practice, and it was not mentioned
in any of the recommendations. Martis et al. mention the practice in their Cochrane systematic
review, and point to that most CTG machines have autocorrelation that frequently averages
the FHR, and that this is not the same as counting FHR for a full minute or other recom-
mended periods of time [48].
We were not able to identify any trials that assessed the optimal timing or duration for aus-
cultations on neonatal and maternal outcomes. Sholapurkar claimed, based on literature
Table 3. Outcome events and meta-analyses.
Outcome No. of studies Events, n/N Doppler Events, n/N Pinard Effect size (95% CI)1 I2 (%)
Apgar score <7 at five minutes2 4 66/4034 63/4402 1.12 (0.65–1.93) 49
Caesarean section 4 696/4034 704/4402 1.16 (0.91–1.49) 84
Composite neonatal outcome3 2 60/2730 63/2798 0.98 (0.69–1.39) 0
Stillbirth and early neonatal death4 4 31/4034 39/4402 0.92 (0.44–1.91) 48
Assisted vaginal delivery 1 104/312 78/625 0.72 (0.48–1.08) -
Detection of abnormal FHR 4 327/4034 226/4402 1.77 (1.29–2.43) 74
1Random effect model.
2One study measured Apgar score <6 at five minutes.
3Fresh stillbirth, early neonatal death < 24 h and admission to Neonatal Intensive care unit. Slightly different definitions in the two studies.
4Slightly different definitions across the studies.
https://doi.org/10.1371/journal.pone.0219573.t003
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reviews and clinical cases, that auscultation conducted after a contraction can result in missing
late decelerations. He recommended auscultation 30–60 s before and after contractions to
assess the baseline FHR and late decelerations [49].
There is no research to guide the optimal techniques for and timing of IA assessment of
fetal heart activity, and most of the guideline recommendations were based on the techniques
described in controlled trials that compared the effects of the Doppler vs. Pinard devices, most
of them from Anglo-Saxon countries. Based on historical anecdotes, the frequency of ausculta-
tion in most European countries was variable (in some cases less than hourly and often every 30
min or so during the first stage of labour). Most routine clinical practice changed to every 15
min, however, following publication of the Dublin trial in 1985 [5]. Nevertheless, a controlled
study has never been undertaken to compare the outcomes of the various frequency intervals.
The definitions have changed over time, with the normal FHR baseline being defined as
120–160 bpm in older studies [27–29, 31, 32] but also in the three contemporary studies from
Tanzania [15, 16, 37]. In 1987, FIGO accepted 110–150 bpm as the normal baseline [50],
which was revised to 110–160 bpm in their 2015 consensus guidelines [3, 51]. National guide-
lines from Denmark and Norway define the normal baseline as 110–150 bpm [40, 41], whereas
other guidelines define normal as 110–160 bpm. There is resistance to implementing the 2015
FIGO recommendations for intrapartum fetal monitoring in Norway and Denmark, the main
reasons being that the 2015 FIGO guidelines are not regarded as evidence based [52, 53]. CTG
combined with ST waveform analysis of the fetal ECG is widespread in the two countries, and
the algorithm for using the ST waveform analysis equipment depends on the 1987 FIGO
guidelines [50].
Midwives and doctors who traditionally auscultated using a Pinard device assessed and
described the findings using other senses and words than when interpreting a CTG tracing.
They described the characteristics of the fetal heart sound as “timbre,” “strength,” and
“rhythm”. A 1972 textbook on obstetrics states that “skilled maternity carers will be able to dis-
criminate the normal timbre from the abnormal” [54]. These descriptive, and possibly clini-
cally significant, words and expressions disappeared from the formal clinical record after CTG
usage became widespread, and auscultation findings are now described using the same words
and expressions as when describing CTG tracings. Only two of the articles [9, 18] and two
guidelines [43, 45] mentioned rhythm in auscultation assessments.
One study provided a decision-making framework for how to assess and perform fetal
monitoring of low-risk women (S1 Fig). The framework was developed, as well as imple-
mented and evaluated, in New Zealand. After implementation, the rate of performing IA
increased, with fewer low-risk women being monitored with CTG [9].
Only two of the 11 included guidelines were assessed as of good quality (Table 3). The main
weakness was that all professions that provide, and women who receive, maternity care had lit-
tle or no influence in the working groups that made the guidelines. Medical doctors, many of
them not skilled in IA, usually dominated the guideline working groups, which may be have
contributed to superficial descriptions of IA methods and FHR characteristics.
The four studies evaluating accuracy, [24, 30, 35, 36], found that individual assessments
could deviate from the values documented on CTG tracings. This discrepancy is possibly
because IA allows practitioners to hear fetal sounds directly, and thus the examiner is being
exposed to information that is different from that recorded by CTG technology. Therefore, it
is probably not easy to define and assess fetal heart sounds uniformly by either auscultation or
CTG. Indeed, studies evaluating how clinicians interpreted CTG tracings found poor interra-
ter agreement [55, 56].
Although IA is the recommended method for intrapartum fetal monitoring, few trials have
evaluated its use during the past two and a half decades. Five trials have assessed IA vs. 20–30
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min CTG upon admission to the labour ward [22, 23, 38, 57, 58]. All five trials–four of them in
a meta-analysis [59]–concluded that admission CTG does not improve neonatal or maternal
outcomes.
Recently, three trials assessed the effect of IA performed by Doppler vs. Pinard devices [15,
16, 18]. We included them, together with a previous trial [26], in a meta-analysis and found no
difference in outcomes in women and babies randomised to a Doppler device vs. a Pinard
device. As all four trials were performed in low-income countries, the comparison should be
repeated in different settings to enable maximum external generalisability. The GRADE assess-
ment of the quality of evidence suggests that the findings for stillbirth and neonatal death were
of moderate quality, but those for other outcomes were less robust, In addition, it found that
the direction of effect and the effect size could change in the future if new studies are included
in the meta-analyses (S1 Text).
The Pinard is produced in different sizes and from different materials. It is possible that size
and material influence on the quality of auscultation. None of the studies described the design
or material of the Pinard model used. Doppler devices and CTG machines were often
described by model.
Limitations
Our scoping review has strengths and limitations. We published the study protocol before we
initiated the literature searches [10]. We did broad literature searches, and it is unlikely that we
missed significant publications. The searches were not limited by language restrictions,
although we realised that we had limited resources for translation. Hence, for the analyses, we
included only literature in languages with which the study group was confident about under-
standing. The searches were limited to scientific literature and guidelines. Including literature
such as textbooks and essays probably would have resulted in more descriptions of IA tech-
niques and protocols. Deviations from our protocol are described in S3 Text.
Conclusions
Implications for future research
No trials have been published that compared protocols for performing IA. In the future, if
such trials are performed to assess perinatal morbidity and mortality, iatrogenic intervention,
and the women’s and practitioners’ views and experiences, they must include large numbers of
women to gain sufficient power because serious adverse outcomes seldom occur in low-risk
women. Because the current evidence suggests that routine (vs. selective) use of CTG does not
benefit women and babies at high-risk and is disadvantageous for those at low-risk, an”all-risk’
trial might be helpful. Another challenge is that the model of care, like e.g., continuity of care,
one-to-one midwifery care, must be considered in such trials.
There is a need to investigate the practice and potential use of IA by performing studies
assessing interrater agreement and to what degree clinicians can detect and describe different
FHR patterns. The skills needed to perform IA using the Pinard device are being lost among
today’s midwives and obstetricians and have more-or-less disappeared in many settings [60,
61]. This means that practitioners will not have the skills to assess fetal well-being in situations
where more advanced tethe machinery is unavailable for any reason, or where they are attend-
ing women in settings where there is no access to CTG or Doppler monitoring.
The benefits of IA, especially with the Pinard device, are increasingly unavailable to
women. Such benefits include the midwife or obstetrician being in direct contact with the
woman herself, which would allow them to observe the range of physiological and behavioural
cues from the woman in conjunction with the aural fetal heart and uterine sounds. Being in
Intermittent auscultation for fetal monitoring
PLOS ONE | https://doi.org/10.1371/journal.pone.0219573 July 10, 2019 16 / 21
close proximity also promotes personal engagement with the woman, increasing the chance of
building a supportive relationship. This situation is less likely to happen if the fetal heart assess-
ment technique creates a physical distance from the woman’s body and the care provider, as is
the case to a lesser extent with a Doppler device and to a much greater extent with a CTG
machine, especially if the latter is wireless and the signal is being read away from the woman
herself, at a staff station or even in another building.
Innovation, leading to new devices for IA, and in signal processing and analysis improving
accuracy, could be useful. The Pinard device is reported to be difficult to use in some maternal
positions, and Doppler devices expose the fetus to ultrasound waves [48]. We identified only
one study that had developed an electronic stethoscope for intermittent fetal monitoring [20].
Implications for practice
There is a need to improve the quality of guideline recommendations by involving user repre-
sentatives and midwives and ensuring that the best evidence is sought and used. Our meta-
analysis found that IA performed with a Doppler device was associated with the detection of
more abnormal FHR patterns. Such detection, however, did not lead to better outcomes for
the babies, nor did it lead to more interventions in the mothers. Currently, there is no evidence
to recommend the Doppler over the Pinard device, or vice versa.
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